Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.

Park SJ, Ye W, Xiao R, Silvin C, Padget M, Hodge JW, Van Waes C, Schmitt NC.

Oral Oncol. 2019 Aug;95:127-135. doi: 10.1016/j.oraloncology.2019.06.016. Epub 2019 Jun 20.

PMID:
31345380
2.

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.

Sun L, Clavijo PE, Robbins Y, Patel P, Friedman J, Greene S, Das R, Silvin C, Van Waes C, Horn LA, Schlom J, Palena C, Maeda D, Zebala J, Allen CT.

JCI Insight. 2019 Apr 4;4(7). pii: 126853. doi: 10.1172/jci.insight.126853. eCollection 2019 Apr 4.

3.

Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.

Zhang J, Chen T, Yang X, Cheng H, Späth SS, Clavijo PE, Chen J, Silvin C, Issaeva N, Su X, Yarbrough WG, Annunziata CM, Chen Z, Van Waes C.

Cancer Res. 2018 Aug 15;78(16):4613-4626. doi: 10.1158/0008-5472.CAN-17-0642. Epub 2018 Jun 19.

4.

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.

Davis RJ, Moore EC, Clavijo PE, Friedman J, Cash H, Chen Z, Silvin C, Van Waes C, Allen C.

Cancer Res. 2017 May 15;77(10):2607-2619. doi: 10.1158/0008-5472.CAN-16-2534. Epub 2017 Mar 31.

5.

Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.

Shaw KL, Garabedian E, Mishra S, Barman P, Davila A, Carbonaro D, Shupien S, Silvin C, Geiger S, Nowicki B, Smogorzewska EM, Brown B, Wang X, de Oliveira S, Choi Y, Ikeda A, Terrazas D, Fu PY, Yu A, Fernandez BC, Cooper AR, Engel B, Podsakoff G, Balamurugan A, Anderson S, Muul L, Jagadeesh GJ, Kapoor N, Tse J, Moore TB, Purdy K, Rishi R, Mohan K, Skoda-Smith S, Buchbinder D, Abraham RS, Scharenberg A, Yang OO, Cornetta K, Gjertson D, Hershfield M, Sokolic R, Candotti F, Kohn DB.

J Clin Invest. 2017 May 1;127(5):1689-1699. doi: 10.1172/JCI90367. Epub 2017 Mar 27.

6.

Avoiding phagocytosis-related artifact in myeloid derived suppressor cell T-lymphocyte suppression assays.

Davis RJ, Silvin C, Allen CT.

J Immunol Methods. 2017 Jan;440:12-18. doi: 10.1016/j.jim.2016.11.006. Epub 2016 Nov 14.

7.

Early-onset stroke and vasculopathy associated with mutations in ADA2.

Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I.

N Engl J Med. 2014 Mar 6;370(10):911-20. doi: 10.1056/NEJMoa1307361. Epub 2014 Feb 19.

8.

Serum biomarkers and trafficking defects in peripheral tissues reflect the severity of retinopathy in three brothers affected by choroideremia.

Strunnikova N, Zein WM, Silvin C, MacDonald IM.

Adv Exp Med Biol. 2012;723:381-7. doi: 10.1007/978-1-4614-0631-0_49. No abstract available.

PMID:
22183356
9.

17β-Estradiol (E-2) administration to male (NZB × SWR)F₁ mice results in increased Id(LN)F₁-reactive memory T-lymphocytes and accelerated glomerulonephritis.

Feng F, Silvin CJ, Fiore NC, Stoll ML, Price KE, Shanley PS, Silverstone AE, Gavalchin J.

Lupus. 2012 Mar;21(3):288-301. doi: 10.1177/0961203311425519. Epub 2011 Nov 7.

PMID:
22065096
10.

Measurement of proliferative responses of cultured lymphocytes.

Muul LM, Heine G, Silvin C, James SP, Candotti F, Radbruch A, Worm M.

Curr Protoc Immunol. 2011 Aug;Chapter 7:Unit7.10. doi: 10.1002/0471142735.im0710s94.

PMID:
21809319
11.

Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells.

Adriani M, Jones KA, Uchiyama T, Kirby MR, Silvin C, Anderson SM, Candotti F.

Blood. 2011 Jun 16;117(24):6608-11. doi: 10.1182/blood-2010-12-322834. Epub 2011 Apr 22.

12.

Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients.

Strunnikova NV, Barb J, Sergeev YV, Thiagarajasubramanian A, Silvin C, Munson PJ, Macdonald IM.

PLoS One. 2009 Dec 22;4(12):e8402. doi: 10.1371/journal.pone.0008402.

13.

Measurement of proliferative responses of cultured lymphocytes.

Muul LM, Silvin C, James SP, Candotti F.

Curr Protoc Immunol. 2008 Aug;Chapter 7:Unit 7.10.1-7.10.24. doi: 10.1002/0471142735.im0710s82.

PMID:
18729064
14.

Dynamic effect of bortezomib on nuclear factor-kappaB activity and gene expression in tumor cells.

Sung MH, Bagain L, Chen Z, Karpova T, Yang X, Silvin C, Voss TC, McNally JG, Van Waes C, Hager GL.

Mol Pharmacol. 2008 Nov;74(5):1215-22. doi: 10.1124/mol.108.049114. Epub 2008 Aug 6.

15.
16.

Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency.

Chinen J, Davis J, De Ravin SS, Hay BN, Hsu AP, Linton GF, Naumann N, Nomicos EY, Silvin C, Ulrick J, Whiting-Theobald NL, Malech HL, Puck JM.

Blood. 2007 Jul 1;110(1):67-73. Epub 2007 Mar 16.

17.

Functional identification of kinases essential for T-cell activation through a genetic suppression screen.

Mack KD, Von Goetz M, Lin M, Venegas M, Barnhart J, Lu Y, Lamar B, Stull R, Silvin C, Owings P, Bih FY, Abo A.

Immunol Lett. 2005 Jan 15;96(1):129-45.

PMID:
15585316
18.

Supplemental Content

Loading ...
Support Center